Through investigation and discovery conducted at its Biomedical Research Institute (BRI), Brigham and Women's Hospital (BWH) is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative.
The BRI sets a new standard of research excellence by supporting ambitious and transformative research; facilitating the powerful, real-time connection that takes BWH research straight from the laboratory bench to the patient's bedside; sparking new discoveries; and offering shared state-of-the-art resources and programs.
May 06, 2008
BWH researchers compared the effectiveness of drugs for osteoporosis in preventing hip and arm fractures and found no difference between a popular class of osteoporosis drugs (bisphosphonates), which all have good evidence in preventing fractures.
|
Feb 14, 2008
BWH researchers report in the February 14, 2008, issue of the New England Journal of Medicine the role genes play in early puberty.
|
Feb 01, 2008
Take two minutes to update yourself on the latest research coming out of Brigham and Women's Hospital's (BWH) Biomedical Research Institute (BRI).
|
Jan 21, 2008
Alexander Turchin, MD, MS, and colleagues found that primary care physicians who were not recently board certified in Internal Medicine were less likely to increase medications for elevated blood pressure.
|
Jan 11, 2008
Neil Bhattacharyya, MD, FACS, and Ajay Wasan, MD, MSc, report that psychiatric comorbidity does not influence symptom reporting or diagnostic accuracy in chronic rhinosinusitis.
|
Jan 10, 2008
BWH researchers part of the Developmental Genome Anatomy Project reported compelling evidence that implicates the neurexin 1 gene (NRXN1) in autism spectrum disorders.
|
Send Feedback to: 
